Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels.

Published in: British journal of cancer (2024)

Ranolazine, alone or in combination with appropriate therapies, could be reformulated as a safe anti-metastatic drug offering many potential advantages over current systemic treatment modalities.

Keyphrases

squamous cell carcinoma
small cell lung cancer
human health
adverse drug
emergency department
cancer therapy
risk assessment
drug delivery
smoking cessation